Apos Medical Assets Ltd. is a global medical device company, owned by leading healthcare fund aMoon and operating in four countries: the United States, the United Kingdom, Singapore and Israel.
AposTherapy® provides a clinically proven, innovative, drug-free, at-home treatment for reducing pain and improving function in patients suffering from knee osteoarthritis and chronic lower back or hip pain.
Apos Medical Assets was founded in 2005 and is headquartered in New York, New York.
The AposTherapy system harnesses biomechanics and neuromuscular training to enhance joint stability, muscle proprioception, and gait patterns. The patient is custom-fitted with specialized shoes that are worn for 30 to 60 minutes a day, providing all the benefits of a comprehensive physical therapy regimen.
Apos Medical Assets distributes the FDA cleared and CE marked AposTherapy® treatment to both large hospitals and private clinicians’ practices. To date, over 70,000 patients suffering from knee, hip, ankle and lower back pain have been treated worldwide.
Apos Medical Assets is backed by aMoon, and company insiders and directors. Apos Medical raised $11M in a Series A extension round on Feb 17, 2020. This brings Apos Medical's total funding to $44.5M to date.